• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Nathalie Khoury, Stephany El-Hayek, Omayr Tarras, Marwan E El-Sabban, Mirvat El-Sibai, Sandra Rizk
  • Medicine, Biology
  • International journal of oncology
  • 2014 (First Publication: 1 April 2014)
  • Kefir, a fermented milk product, exhibits anti‑tumoral activity in vivo; yet its mechanism of action remains elusive. Recent studies have focused on the mechanism of action of kefir on cancer cellsExpand
  • Rana Khalife, Mohammad Hassan Hodroj, Rajaa Fakhoury, Sandra Rizk
  • Medicine
  • Planta medica
  • 2016 (First Publication: 5 February 2016)
  • Topotecan, a topoisomerase I inhibitor, is an anticancer drug widely used in the therapy of lung, ovarian, colorectal, and breast adenocarcinoma. Due to the primary dose-limiting toxicity ofExpand
  • Ghinwa M. Barakat, Mohamed E Moustafa, Ibrahim Khalifeh, Mohammad Hassan Hodroj, Anwar B. Bikhazi, Sandra Rizk
  • Medicine
  • Journal of Physiology and Biochemistry
  • 2017 (First Publication: 1 August 2016)
  • The mechanisms by which exendin-4 and selenium exert their antidiabetic actions are still unclear. Here, we investigated the effects of exendin-4 or selenium administration on the expression ofExpand
  • Rana Khalife, Stephany El-Hayek, Omayr Tarras, Mohammad Hassan Hodroj, Sandra Rizk
  • Medicine
  • Clinical lymphoma, myeloma & leukemia
  • 2014 (First Publication: 1 September 2014)
  • BACKGROUND Topotecan has shown promising antineoplastic activity in solid tumors and acute leukemia. Because of the primary dose-limiting toxicity of topotecan, it is necessary to identify otherExpand